Carregant...
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
BACKGROUND: The reemergence of yellow fever virus (YFV) in Africa and Brazil, and massive vaccine campaigns triggered to contain the outbreaks, have raised concerns over blood transfusion safety and availability with increased risk of YFV transfusion‐transmitted infections (TTIs) by native and vacci...
Guardat en:
| Publicat a: | Transfusion |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078960/ https://ncbi.nlm.nih.gov/pubmed/31957887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15673 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|